Bioanalytical

Lambda Therapeutic Research offers a comprehensive suite of bioanalytical capabilities specializing in cell-based assays, biomarkers, immunogenicity, and pharmacokinetics (PK).

Bioanalytical Lab

 With state-of-the-art facilities and a team of experienced scientists, Lambda provides end-to-end solutions for the analysis of small molecules, biomarkers, biologics, and therapeutic elemental drugs. Our team has extensive experience in developing validated and qualified methods for generic and NCE molecules, including ultra-trace detection, endogenous, and chiral assays.

Bioanalytical Methods Assay List:

Access our latest assay list showcasing our extensive Bioanalytical Assay capabilities, boasting over 1400 validated methods. Our Bioanalytical Labs in India and Canada have successfully conducted diverse Bioanalytical Assays across a wide range of biological matrices.

The assay list is categorized as follows:

Recently Validated Methods

Recently Validated Methods

Premium Methods

Premium Methods

Large Molecules / Therapeutic Proteins / Biosimilars

Large Molecules / Therapeutic Proteins / Biosimilars

Immunogenicity Assessment

Immunogenicity Assessment

Small Molecules

Small Molecules

New Chemical Entities

New Chemical Entities

In-Vitro Studies

In-Vitro Studies

PD Markers

PD Markers

Evaluation of the Effectiveness of Healthcare Hygiene Products

Evaluation of the Effectiveness of Healthcare Hygiene Products

Explore the diverse array of assays we offer, representing our commitment to excellence in bioanalysis.

India

Infrastructure

Expertise & Capabilities

Canada

Infrastructure

Expertise & Capabilities

Small Molecule Experience

Low detection assay

Endogenous assay

Protein bound and unbound assay

Conjugated and unconjugated assay

Vitamin product assay

Fat analysis in food and fecal

Light sensitive assay

Chiral assay

Liposomal encapsulated and un-encapsulated assay

Hormonal product assay

Assay for highly unstable molecules

Biphosphonate assay

Our Presence

We see the current vigorous growth the Group and are confident about